{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:19:11Z","timestamp":1794071951618,"version":"4.8.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Abnormal phosphorylation of the microtubule-binding protein tau in the brain is a key pathological marker for Alzheimer\u2019s disease and additional neurodegenerative tauopathies. However, how hyperphosphorylated tau causes cellular dysfunction or death that underlies neurodegeneration remains an unsolved question critical for the understanding of disease mechanism and the design of efficacious drugs. Using a recombinant hyperphosphorylated tau protein (p-tau) synthesized by the PIMAX approach, we examined how cells responded to the cytotoxic tau and explored means to enhance cellular resistance to tau attack. Upon p-tau uptake, the intracellular calcium levels rose promptly. Gene expression analyses revealed that p-tau potently triggered endoplasmic reticulum (ER) stress, unfolded protein response (UPR), ER stress-associated apoptosis, and pro-inflammation in cells. Proteomics studies showed that p-tau diminished heme oxygenase-1 (HO-1), an ER stress-associated anti-inflammation and anti-oxidative stress regulator, while stimulated the accumulation of MIOS and other proteins. p-Tau-induced ER stress-associated apoptosis and pro-inflammation are ameliorated by apomorphine, a brain-permeable prescription drug widely used to treat Parkinson\u2019s disease symptoms, and by overexpression of HO-1. Our results reveal probable cellular functions targeted by hyperphosphorylated tau. Some of these dysfunctions and stress responses have been linked to neurodegeneration in Alzheimer\u2019s disease. The observations that the ill effects of p-tau can be mitigated by a small compound and by overexpressing HO-1 that is otherwise diminished in the treated cells inform new directions of Alzheimer\u2019s disease drug discovery.<\/jats:p>","DOI":"10.1007\/s12035-023-03689-x","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:24:21Z","timestamp":1698971061000},"page":"2653-2671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine"],"prefix":"10.1007","volume":"61","author":[{"given":"Zhenfeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Tien Chien","family":"Hagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yi","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-5344","authenticated-orcid":false,"given":"Min-Hao","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"3689_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C (2016) Molecular genetics of early-onset Alzheimer's disease revisited. Alzheimers Dement 12:733\u2013748","journal-title":"Alzheimers Dement"},{"key":"3689_CR2","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913\u20134917","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3689_CR3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3689_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321","journal-title":"Nat Rev Neurosci"},{"key":"3689_CR5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/369488a0","volume":"369","author":"A Harada","year":"1994","unstructured":"Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y et al (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369:488\u2013491","journal-title":"Nature"},{"key":"3689_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","volume":"114","author":"HN Dawson","year":"2001","unstructured":"Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179\u20131187","journal-title":"J Cell Sci"},{"key":"3689_CR7","doi-asserted-by":"publisher","first-page":"873270","DOI":"10.1155\/2012\/873270","volume":"2012","author":"YD Ke","year":"2012","unstructured":"Ke YD, Suchowerska AK, van der Hoven J, De Silva DM, Wu CW, van Eersel J, Ittner A, Ittner LM (2012) Lessons from tau-deficient mice. Int j Alzheimer's disease 2012:873270","journal-title":"Int j Alzheimer's disease"},{"key":"3689_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(99)00964-7","volume":"279","author":"S Ikegami","year":"2000","unstructured":"Ikegami S, Harada A, Hirokawa N (2000) Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci Lett 279:129\u2013132","journal-title":"Neurosci Lett"},{"key":"3689_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-9-29","volume":"9","author":"P Lei","year":"2014","unstructured":"Lei P, Ayton S, Moon S, Zhang Q, Volitakis I, Finkelstein DI, Bush AI (2014) Motor and cognitive deficits in aged tau knockout mice in two background strains. Molecular neurodegeneration 9:29\u201329","journal-title":"Molecular neurodegeneration"},{"key":"3689_CR10","doi-asserted-by":"publisher","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E Kopke","year":"1993","unstructured":"Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374\u201324384","journal-title":"J Biol Chem"},{"key":"3689_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","volume":"351","author":"S Khatoon","year":"1994","unstructured":"Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351:80\u201384","journal-title":"FEBS Lett"},{"key":"3689_CR12","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","volume":"91","author":"AC Alonso","year":"1994","unstructured":"Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A 91:5562\u20135566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3689_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"3689_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","volume":"21","author":"M Jucker","year":"2018","unstructured":"Jucker M, Walker LC (2018) Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases. Nature neurosci 21:1341\u20131349","journal-title":"Nature neurosci"},{"key":"3689_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Sci 316:750\u2013754","journal-title":"Sci"},{"key":"3689_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum JM, Schilling S, Cynis H, Silva A, Swanson E, Wangsanut T, Tayler K, Wiltgen B et al (2012) Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-\u03b2. Nature 485:651\u2013655","journal-title":"Nature"},{"key":"3689_CR17","doi-asserted-by":"publisher","first-page":"a006254","DOI":"10.1101\/cshperspect.a006254","volume":"2","author":"M Goedert","year":"2012","unstructured":"Goedert M, Ghetti B, Spillantini MG (2012) Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med 2:a006254","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3689_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol appl neurobiol 41:3\u201323","journal-title":"Neuropathol appl neurobiol"},{"key":"3689_CR19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S et al (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705","journal-title":"Nature"},{"key":"3689_CR20","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Sci 282:1914\u20131917","journal-title":"Sci"},{"key":"3689_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351","journal-title":"Neuron"},{"key":"3689_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","volume":"165","author":"A Bellucci","year":"2004","unstructured":"Bellucci A, Westwood AJ, Ingram E, Casamenti F, Goedert M, Spillantini MG (2004) Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol 165:1643\u20131652","journal-title":"Am J Pathol"},{"key":"3689_CR23","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M et al (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340\u20139351","journal-title":"J Neurosci"},{"key":"3689_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 33:1024\u20131037","journal-title":"J Neurosci"},{"key":"3689_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00005072-199902000-00008","volume":"58","author":"R Morsch","year":"1999","unstructured":"Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188\u2013197","journal-title":"J Neuropathol Exp Neurol"},{"key":"3689_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T G\u00f3mez-Isla","year":"1997","unstructured":"G\u00f3mez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann neurol 41:17\u201324","journal-title":"Ann neurol"},{"key":"3689_CR27","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1523\/JNEUROSCI.4637-04.2005","volume":"25","author":"C Andorfer","year":"2005","unstructured":"Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 25:5446\u20135454","journal-title":"J Neurosci"},{"key":"3689_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K SantaCruz","year":"2005","unstructured":"SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M et al (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Sci 309:476\u2013481","journal-title":"Sci"},{"key":"3689_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1062382","volume":"293","author":"CW Wittmann","year":"2001","unstructured":"Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Sci 293:711\u2013714","journal-title":"Sci"},{"key":"3689_CR30","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","volume":"57","author":"M Liu","year":"2020","unstructured":"Liu M, Sui D, Dexheimer T, Hovde S, Deng X, Wang KW, Lin HL, Chien HT et al (2020) Hyperphosphorylation renders tau prone to aggregate and to cause cell death. Molecular neurobiol 57:4704\u20134719","journal-title":"Molecular neurobiol"},{"key":"3689_CR31","doi-asserted-by":"publisher","first-page":"43223","DOI":"10.1074\/jbc.M112.396176","volume":"287","author":"K Flach","year":"2012","unstructured":"Flach K, Hilbrich I, Schiffmann A, Gartner U, Kruger M, Leonhardt M, Waschipky H, Wick L et al (2012) Tau oligomers impair artificial membrane integrity and cellular viability. J Biol Chem 287:43223\u201343233","journal-title":"J Biol Chem"},{"key":"3689_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2051-5960-2-56","volume":"2","author":"CA Lasagna-Reeves","year":"2014","unstructured":"Lasagna-Reeves CA, Sengupta U, Castillo-Carranza D, Gerson JE, Guerrero-Munoz M, Troncoso JC, Jackson GR, Kayed R (2014) The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes. Acta Neuropathol Commun 2:56","journal-title":"Acta Neuropathol Commun"},{"key":"3689_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3389\/fnins.2019.00698","volume":"13","author":"M Perez","year":"2019","unstructured":"Perez M, Avila J, Hernandez F (2019) Propagation of tau via extracellular vesicles. Front neurosci 13:698","journal-title":"Front neurosci"},{"key":"3689_CR34","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.celrep.2018.10.078","volume":"25","author":"M Merezhko","year":"2018","unstructured":"Merezhko M, Brunello CA, Yan X, Vihinen H, Jokitalo E, Uronen RL, Huttunen HJ (2018) Secretion of tau via an unconventional non-vesicular mechanism. Cell Rep 25:2027\u20132035.e2024","journal-title":"Cell Rep"},{"key":"3689_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, Leshuk C, Hernandez I et al (2020) LRP1 is a master regulator of tau uptake and spread. Nature 580:381\u2013385","journal-title":"Nature"},{"key":"3689_CR36","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic M, Niroomand S, Drolet RE, Yao L, Gaspar RC, Hatcher NG, Schachter J, Renger JJ et al (2015) Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells. J Neurosci 35:14234\u201314250","journal-title":"J Neurosci"},{"key":"3689_CR37","doi-asserted-by":"publisher","first-page":"14893","DOI":"10.1074\/jbc.M115.652693","volume":"290","author":"H Mirbaha","year":"2015","unstructured":"Mirbaha H, Holmes BB, Sanders DW, Bieschke J, Diamond MI (2015) Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation. J Biol Chem 290:14893\u201314903","journal-title":"J Biol Chem"},{"key":"3689_CR38","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845\u201312852","journal-title":"J Biol Chem"},{"key":"3689_CR39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2018.00267","volume":"12","author":"SL DeVos","year":"2018","unstructured":"DeVos SL, Corjuc BT, Oakley DH, Nobuhara CK, Bannon RN, Chase A, Commins C, Gonzalez JA et al (2018) Synaptic tau seeding precedes tau pathology in human Alzheimer's disease brain. Front neurosci 12:267","journal-title":"Front neurosci"},{"key":"3689_CR40","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1074\/jbc.M115.709485","volume":"291","author":"JC Polanco","year":"2016","unstructured":"Polanco JC, Scicluna BJ, Hill AF, Gotz J (2016) Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner. J Biol Chem 291:12445\u201312466","journal-title":"J Biol Chem"},{"key":"3689_CR41","doi-asserted-by":"crossref","unstructured":"Furman JL, Vaquer-Alicea J, White CL, Cairns NJ, Nelson PT, Diamond MI (2016) Widespread tau seeding activity at early Braak stages. Acta Neuropathol","DOI":"10.1007\/s00401-016-1644-z"},{"key":"3689_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189\u2013210","journal-title":"Annu Rev Neurosci"},{"key":"3689_CR43","doi-asserted-by":"crossref","unstructured":"Kou X, Shi X, Pang Z, Yang A, Shen R, Zhao L (2023) A review on the natural components applied as lead compounds for potential multi-target anti-AD theranostic agents. Curr Med Chem","DOI":"10.2174\/0929867330666230125153027"},{"key":"3689_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/1871524919666190820160053","volume":"19","author":"KA Singh","year":"2019","unstructured":"Singh KA, Singh KS, Nandi KM, Mishra G, Maurya A, Rai A, Rai KG, Awasthi R et al (2019) Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer\u2019s disease. Central Nervous Syst Agents Med Chem 19:154\u2013170","journal-title":"Central Nervous Syst Agents Med Chem"},{"key":"3689_CR45","doi-asserted-by":"publisher","first-page":"19011","DOI":"10.1038\/s41598-019-55419-w","volume":"9","author":"F Lo Cascio","year":"2019","unstructured":"Lo Cascio F, Puangmalai N, Ellsworth A, Bucchieri F, Pace A, Palumbo Piccionello A, Kayed R (2019) Toxic tau oligomers modulated by novel curcumin derivatives. Sci rep 9:19011","journal-title":"Sci rep"},{"key":"3689_CR46","doi-asserted-by":"publisher","first-page":"5578574","DOI":"10.1155\/2021\/5578574","volume":"2021","author":"AK Singh","year":"2021","unstructured":"Singh AK, Rai SN, Maurya A, Mishra G, Awasthi R, Shakya A, Chellappan DK, Dua K et al (2021) Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease. Evidence-Based Complement Alternat Med 2021:5578574","journal-title":"Evidence-Based Complement Alternat Med"},{"key":"3689_CR47","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1021\/bi9006435","volume":"48","author":"A Crowe","year":"2009","unstructured":"Crowe A, Huang W, Ballatore C, Johnson RL, Hogan AM, Huang R, Wichterman J, McCoy J et al (2009) Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochem 48:7732\u20137745","journal-title":"Biochem"},{"key":"3689_CR48","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1021\/jm100138f","volume":"53","author":"C Ballatore","year":"2010","unstructured":"Ballatore C, Brunden KR, Piscitelli F, James MJ, Crowe A, Yao Y, Hyde E, Trojanowski JQ et al (2010) Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation. J Med Chem 53:3739\u20133747","journal-title":"J Med Chem"},{"key":"3689_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/156720507783018307","volume":"4","author":"I Khlistunova","year":"2007","unstructured":"Khlistunova I, Pickhardt M, Biernat J, Wang Y, Mandelkow EM, Mandelkow E (2007) Inhibition of tau aggregation in cell models of tauopathy. Curr Alzheimer Res 4:544\u2013546","journal-title":"Curr Alzheimer Res"},{"key":"3689_CR50","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1021\/bi700878g","volume":"46","author":"M Pickhardt","year":"2007","unstructured":"Pickhardt M, Larbig G, Khlistunova I, Coksezen A, Meyer B, Mandelkow EM, Schmidt B, Mandelkow E (2007) Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. Biochem 46:10016\u201310023","journal-title":"Biochem"},{"key":"3689_CR51","doi-asserted-by":"publisher","first-page":"e52389","DOI":"10.1371\/journal.pone.0052389","volume":"7","author":"M Hosokawa","year":"2012","unstructured":"Hosokawa M, Arai T, Masuda-Suzukake M, Nonaka T, Yamashita M, Akiyama H, Hasegawa M (2012) Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice. PLoS One 7:e52389","journal-title":"PLoS One"},{"key":"3689_CR52","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M408714200","volume":"280","author":"S Taniguchi","year":"2005","unstructured":"Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614\u20137623","journal-title":"J Biol Chem"},{"key":"3689_CR53","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","volume":"288","author":"A Crowe","year":"2013","unstructured":"Crowe A, James MJ, Lee VM, Smith AB 3rd, Trojanowski JQ, Ballatore C, Brunden KR (2013) Aminothienopyridazines and methylene blue affect tau fibrillization via cysteine oxidation. J Biol Chem 288:11024\u201311037","journal-title":"J Biol Chem"},{"key":"3689_CR54","first-page":"i4474","volume":"354","author":"J Wise","year":"2016","unstructured":"Wise J (2016) No \"breakthrough\" in Alzheimer's disease. BMJ (Clinical research ed) 354:i4474","journal-title":"BMJ (Clinical research ed)"},{"key":"3689_CR55","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3233\/JAD-181001","volume":"68","author":"Y Soeda","year":"2019","unstructured":"Soeda Y, Saito M, Maeda S, Ishida K, Nakamura A, Kojima S, Takashima A (2019) Methylene blue inhibits formation of tau fibrils but not of granular tau oligomers: a plausible key to understanding failure of a clinical trial for Alzheimer's disease. J Alzheimers Dis 68:1677\u20131686","journal-title":"J Alzheimers Dis"},{"key":"3689_CR56","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","volume":"388","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P et al (2016) Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet (London England) 388:2873\u20132884","journal-title":"Lancet (London England)"},{"key":"3689_CR57","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1471-4159.1996.67031183.x","volume":"67","author":"M Perez","year":"1996","unstructured":"Perez M, Valpuesta JM, Medina M (1996) Montejo de Garcini E, Avila J: Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J Neurochem 67:1183\u20131190","journal-title":"J Neurochem"},{"key":"3689_CR58","doi-asserted-by":"publisher","first-page":"16551","DOI":"10.1038\/s41598-020-73680-2","volume":"10","author":"M Liu","year":"2020","unstructured":"Liu M, Dexheimer T, Sui D, Hovde S, Deng X, Kwok R, Bochar DA, Kuo MH (2020) Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions. Sci rep 10:16551","journal-title":"Sci rep"},{"key":"3689_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1074\/mcp.O114.044412","volume":"14","author":"D Sui","year":"2015","unstructured":"Sui D, Xu X, Ye X, Liu M, Mianecki M, Rattanasinchai C, Buehl C, Deng X et al (2015) Protein interaction module-assisted function X (PIMAX) approach to producing challenging proteins including hyperphosphorylated tau and active CDK5\/p25 kinase complex. Mol Cell Proteo 14:251\u2013262","journal-title":"Mol Cell Proteo"},{"key":"3689_CR60","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3233\/JAD-160344","volume":"58","author":"N Nakamura","year":"2017","unstructured":"Nakamura N, Ohyagi Y, Imamura T, Yanagihara YT, Iinuma KM, Soejima N, Murai H, Yamasaki R et al (2017) Apomorphine therapy for neuronal insulin resistance in a mouse model of Alzheimer's disease. J Alzheimers Dis 58:1151\u20131161","journal-title":"J Alzheimers Dis"},{"key":"3689_CR61","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.162.4.683","volume":"162","author":"K Yaffe","year":"2005","unstructured":"Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D (2005) Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am j psychiat 162:683\u2013690","journal-title":"Am j psychiat"},{"key":"3689_CR62","doi-asserted-by":"publisher","first-page":"104249","DOI":"10.1016\/j.ebiom.2022.104249","volume":"84","author":"EE Congdon","year":"2022","unstructured":"Congdon EE, Pan R, Jiang Y, Sandusky-Beltran LA, Dodge A, Lin Y, Liu M, Kuo MH et al (2022) Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity. EBioMedicine 84:104249","journal-title":"EBioMedicine"},{"key":"3689_CR63","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Stomrud E, Smith R, Palmqvist S, Mattsson N, Airey DC, Proctor NK, Chai X et al (2020) Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease. Nature Commun 11:1683","journal-title":"Nature Commun"},{"key":"3689_CR64","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, Su Y, Chen Y et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. Jama 324:772\u2013781","journal-title":"Jama"},{"key":"3689_CR65","first-page":"i90","volume":"352","author":"SL Gray","year":"2016","unstructured":"Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB (2016) Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ (Clinical research ed) 352:i90","journal-title":"BMJ (Clinical research ed)"},{"key":"3689_CR66","first-page":"g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Begaud B (2014) Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ (Clinical research ed) 349:g5205","journal-title":"BMJ (Clinical research ed)"},{"key":"3689_CR67","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ (2020) Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21:421\u2013438","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3689_CR68","doi-asserted-by":"crossref","unstructured":"Hashimoto S, Saido TC (2018) Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease. Open biol:8","DOI":"10.1098\/rsob.180024"},{"key":"3689_CR69","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/febs.14332","volume":"285","author":"Y Gerakis","year":"2018","unstructured":"Gerakis Y, Hetz C (2018) Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer's disease. FEBS J 285:995\u20131011","journal-title":"FEBS J"},{"key":"3689_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.neuropharm.2017.11.016","volume":"136","author":"LE Santos","year":"2018","unstructured":"Santos LE, Ferreira ST (2018) Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease. Neuropharmacol 136:350\u2013360","journal-title":"Neuropharmacol"},{"key":"3689_CR71","doi-asserted-by":"publisher","first-page":"25935","DOI":"10.1074\/jbc.R400008200","volume":"279","author":"K Zhang","year":"2004","unstructured":"Zhang K, Kaufman RJ (2004) Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279:25935\u201325938","journal-title":"J Biol Chem"},{"key":"3689_CR72","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature07203","volume":"454","author":"K Zhang","year":"2008","unstructured":"Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455\u2013462","journal-title":"Nature"},{"key":"3689_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","volume":"13","author":"I Tabas","year":"2011","unstructured":"Tabas I, Ron D (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13:184\u2013190","journal-title":"Nat Cell Biol"},{"key":"3689_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-60327-017-5_14","volume":"559","author":"A Fribley","year":"2009","unstructured":"Fribley A, Zhang K, Kaufman RJ (2009) Regulation of apoptosis by the unfolded protein response. Methods Mol Biol 559:191\u2013204","journal-title":"Methods Mol Biol"},{"key":"3689_CR75","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1083\/jcb.200904060","volume":"186","author":"G Li","year":"2009","unstructured":"Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR, Tabas I (2009) Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol 186:783\u2013792","journal-title":"J Cell Biol"},{"key":"3689_CR76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3233\/JAD-2010-1271","volume":"19","author":"MA Tremblay","year":"2010","unstructured":"Tremblay MA, Acker CM, Davies P (2010) Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase. Arg J Alzheimers Dis 19:721\u2013733","journal-title":"Arg J Alzheimers Dis"},{"key":"3689_CR77","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11:2301\u20132319","journal-title":"Nat Protoc"},{"key":"3689_CR78","doi-asserted-by":"crossref","unstructured":"Barth\u00e9lemy NR, Horie K, Sato C, Bateman RJ (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. J experiment med:217","DOI":"10.1084\/jem.20200861"},{"key":"3689_CR79","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proceed Nat Academ Sci 110:9535\u20139540","journal-title":"Proceed Nat Academ Sci"},{"key":"3689_CR80","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/brain\/awx342","volume":"141","author":"M d\u2019Orange","year":"2017","unstructured":"d\u2019Orange M, Aur\u00e9gan G, Cheramy D, Gaudin-Gu\u00e9rif M, Lieger S, Guillermier M, Stimmer L, Jos\u00e9phine C et al (2017) Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat. Brain 141:535\u2013549","journal-title":"Brain"},{"key":"3689_CR81","doi-asserted-by":"publisher","first-page":"479","DOI":"10.4149\/gpb_2021031","volume":"40","author":"O Cehlar","year":"2021","unstructured":"Cehlar O, Bagarova O, Hornakova L, Skrabana R (2021) The structure of the unstructured: mosaic of tau protein linear motifs obtained by high-resolution techniques and molecular simulation. Gen Physiol Biophys 40:479\u2013493","journal-title":"Gen Physiol Biophys"},{"key":"3689_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM (2017) Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem 86:27\u201368","journal-title":"Annu Rev Biochem"},{"key":"3689_CR83","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1385\/MN:21:1-2:083","volume":"21","author":"LC Walker","year":"2000","unstructured":"Walker LC, LeVine H (2000) The cerebral proteopathies. Molecular neurobiology 21:83\u201395","journal-title":"Molecular neurobiology"},{"key":"3689_CR84","doi-asserted-by":"publisher","first-page":"11731","DOI":"10.1073\/pnas.1109035108","volume":"108","author":"MC Bassik","year":"2011","unstructured":"Bassik MC, Kampmann M (2011) Knocking out the door to tunicamycin entry. Proc Natl Acad Sci U S A 108:11731\u201311732","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3689_CR85","doi-asserted-by":"publisher","first-page":"R660","DOI":"10.1016\/j.cub.2014.05.033","volume":"24","author":"PS Gurel","year":"2014","unstructured":"Gurel PS, Hatch AL, Higgs HN (2014) Connecting the cytoskeleton to the endoplasmic reticulum and Golgi. Curr Biol 24:R660\u2013r672","journal-title":"Curr Biol"},{"key":"3689_CR86","doi-asserted-by":"crossref","unstructured":"Perkins HT, Allan V (2021) Intertwined and finely balanced: endoplasmic reticulum morphology, dynamics, function, and diseases. Cells 10","DOI":"10.3390\/cells10092341"},{"key":"3689_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-4-20","volume":"4","author":"P Marambaud","year":"2009","unstructured":"Marambaud P, Dreses-Werringloer U, Vingtdeux V (2009) Calcium signaling in neurodegeneration. Molecular Neurodegen 4:20","journal-title":"Molecular Neurodegen"},{"key":"3689_CR88","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/alz.12325","volume":"17","author":"D Datta","year":"2021","unstructured":"Datta D, Leslie SN, Wang M, Morozov YM, Yang S, Mentone S, Zeiss C, Duque A et al (2021) Age-related calcium dysregulation linked with tau pathology and impaired cognition in non-human primates. Alzheimer's Dementia 17:920\u2013932","journal-title":"Alzheimer's Dementia"},{"key":"3689_CR89","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ceca.2016.04.010","volume":"60","author":"AU Joshi","year":"2016","unstructured":"Joshi AU, Kornfeld OS, Mochly-Rosen D (2016) The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: a tangled duo unchained. Cell Calcium 60:218\u2013234","journal-title":"Cell Calcium"},{"key":"3689_CR90","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-210497","volume":"83","author":"F Cioffi","year":"2021","unstructured":"Cioffi F, Adam RHI, Bansal R, Broersen K (2021) A review of oxidative stress products and related genes in early Alzheimer's disease. J Alzheimers Dis 83:977\u20131001","journal-title":"J Alzheimers Dis"},{"key":"3689_CR91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1054\/ceca.1999.0095","volume":"27","author":"KR Gee","year":"2000","unstructured":"Gee KR, Brown KA, Chen WN, Bishop-Stewart J, Gray D, Johnson I (2000) Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell Calcium 27:97\u2013106","journal-title":"Cell Calcium"},{"key":"3689_CR92","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.04-3210fje","volume":"19","author":"Q Wang","year":"2005","unstructured":"Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, Montine TJ (2005) Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. Faseb j 19:869\u2013871","journal-title":"Faseb j"},{"key":"3689_CR93","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awaa223","volume":"143","author":"E Drummond","year":"2020","unstructured":"Drummond E, Pires G, MacMurray C, Askenazi M, Nayak S, Bourdon M, Safar J, Ueberheide B et al (2020) Phosphorylated tau interactome in the human Alzheimer's disease brain. Brain 143:2803\u20132817","journal-title":"Brain"},{"key":"3689_CR94","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2741\/s310","volume":"4","author":"S Oddo","year":"2012","unstructured":"Oddo S (2012) The role of mTOR signaling in Alzheimer disease. Front Biosci (Schol Ed) 4:941\u2013952","journal-title":"Front Biosci (Schol Ed)"},{"key":"3689_CR95","doi-asserted-by":"publisher","first-page":"649456","DOI":"10.1155\/2012\/649456","volume":"2012","author":"SV Guttula","year":"2012","unstructured":"Guttula SV, Allam A, Gumpeny RS (2012) Analyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes. Int j Alzheimer's disease 2012:649456","journal-title":"Int j Alzheimer's disease"},{"key":"3689_CR96","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41577-020-00491-x","volume":"21","author":"NK Campbell","year":"2021","unstructured":"Campbell NK, Fitzgerald HK, Dunne A (2021) Regulation of inflammation by the antioxidant haem oxygenase 1. Nat Rev Immunol 21:411\u2013425","journal-title":"Nat Rev Immunol"},{"key":"3689_CR97","doi-asserted-by":"crossref","unstructured":"Consoli V, Sorrenti V, Grosso S, Vanella L (2021) Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules:11","DOI":"10.3390\/biom11040589"},{"key":"3689_CR98","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3389\/fnins.2018.00712","volume":"12","author":"D Chiabrando","year":"2018","unstructured":"Chiabrando D, Fiorito V, Petrillo S, Tolosano E (2018) Unraveling the Role of Heme in Neurodegeneration. Front neurosci 12:712","journal-title":"Front neurosci"},{"key":"3689_CR99","doi-asserted-by":"crossref","unstructured":"G\u00e1ll T, Balla G, Balla J (2019) Heme, heme oxygenase, and endoplasmic reticulum stress-a new insight into the pathophysiology of vascular diseases. Int J Mol Sci 20","DOI":"10.3390\/ijms20153675"},{"key":"3689_CR100","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3233\/JAD-200720","volume":"78","author":"Z Si","year":"2020","unstructured":"Si Z, Wang X (2020) The neuroprotective and neurodegeneration effects of heme oxygenase-1 in Alzheimer's disease. J Alzheimers Dis 78:1259\u20131272","journal-title":"J Alzheimers Dis"},{"key":"3689_CR101","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pneurobio.2018.06.008","volume":"172","author":"HM Schipper","year":"2019","unstructured":"Schipper HM, Song W, Tavitian A, Cressatti M (2019) The sinister face of heme oxygenase-1 in brain aging and disease. Prog Neurobiol 172:40\u201370","journal-title":"Prog Neurobiol"},{"key":"3689_CR102","doi-asserted-by":"publisher","first-page":"e0141933","DOI":"10.1371\/journal.pone.0141933","volume":"10","author":"A Cinti","year":"2015","unstructured":"Cinti A, De Giorgi M, Chisci E, Arena C, Galimberti G, Farina L, Bugarin C, Rivolta I et al (2015) Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-\u03b1-induced injury in vitro. PLoS One 10:e0141933","journal-title":"PLoS One"},{"key":"3689_CR103","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1099\/vir.0.83428-0","volume":"89","author":"GA Luke","year":"2008","unstructured":"Luke GA, de Felipe P, Lukashev A, Kallioinen SE, Bruno EA, Ryan MD (2008) Occurrence, function and evolutionary origins of '2A-like' sequences in virus genomes. J Gen Virol 89:1036\u20131042","journal-title":"J Gen Virol"},{"key":"3689_CR104","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","volume":"71","author":"M Brini","year":"2014","unstructured":"Brini M, Cal\u00ec T, Ottolini D, Carafoli E (2014) Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci 71:2787\u20132814","journal-title":"Cell Mol Life Sci"},{"key":"3689_CR105","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jalz.2017.01.005","volume":"13","author":"C Overk","year":"2017","unstructured":"Overk C, Masliah E (2017) Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease. Alzheimers Dement 13:183\u2013185","journal-title":"Alzheimers Dement"},{"key":"3689_CR106","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"FM LaFerla","year":"2002","unstructured":"LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3:862\u2013872","journal-title":"Nat Rev Neurosci"},{"key":"3689_CR107","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1074\/jbc.M006104200","volume":"276","author":"F Zhao","year":"2001","unstructured":"Zhao F, Li P, Chen SR, Louis CF, Fruen BR (2001) Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem 276:13810\u201313816","journal-title":"J Biol Chem"},{"key":"3689_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He Z, McBride JD, Xu H, Changolkar L, Kim SJ, Zhang B, Narasimhan S, Gibbons GS et al (2020) Transmission of tauopathy strains is independent of their isoform composition. Nat Commun 11:7","journal-title":"Nat Commun"},{"key":"3689_CR109","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","volume":"127","author":"Z Ahmed","year":"2014","unstructured":"Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, Parhizkar S, Ward MA et al (2014) A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 127:667\u2013683","journal-title":"Acta Neuropathol"},{"key":"3689_CR110","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93:11213\u201311218","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3689_CR111","doi-asserted-by":"publisher","first-page":"120861","DOI":"10.1016\/j.lfs.2022.120861","volume":"306","author":"S Asher","year":"2022","unstructured":"Asher S, Priefer R (2022) Alzheimer's disease failed clinical trials. Life Sci 306:120861","journal-title":"Life Sci"},{"key":"3689_CR112","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1242\/jcs.168922","volume":"128","author":"S Dokudovskaya","year":"2015","unstructured":"Dokudovskaya S, Rout MP (2015) SEA you later alli-GATOR--a dynamic regulator of the TORC1 stress response pathway. J Cell Sci 128:2219\u20132228","journal-title":"J Cell Sci"},{"key":"3689_CR113","first-page":"107","volume":"40","author":"SC Johnson","year":"2015","unstructured":"Johnson SC, Sangesland M, Kaeberlein M, Rabinovitch PS (2015) Modulating mTOR in aging and health. Interdiscip Top Gerontol 40:107\u2013127","journal-title":"Interdiscip Top Gerontol"},{"key":"3689_CR114","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-981-13-3540-2_10","volume":"1128","author":"H Liang","year":"2019","unstructured":"Liang H, Nie J, Van Skike CE, Valentine JM, Orr ME (2019) Mammalian target of rapamycin at the crossroad between Alzheimer's disease and diabetes. Adv experiment med biol 1128:185\u2013225","journal-title":"Adv experiment med biol"},{"key":"3689_CR115","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.1073\/pnas.1002555107","volume":"107","author":"W Han","year":"2010","unstructured":"Han W, Li C (2010) Linking type 2 diabetes and Alzheimer's disease. Proceed Nat Acad Sci United States of Am 107:6557\u20136558","journal-title":"Proceed Nat Acad Sci United States of Am"},{"key":"3689_CR116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mus.26782","volume":"61","author":"SA Heller","year":"2020","unstructured":"Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-Dreifuss muscular dystrophy. Muscle nerve 61:436\u2013448","journal-title":"Muscle nerve"},{"key":"3689_CR117","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcdb.2013.12.010","volume":"29","author":"S Cartwright","year":"2014","unstructured":"Cartwright S, Karakesisoglou I (2014) Nesprins in health and disease. Semin Cell Dev Biol 29:169\u2013179","journal-title":"Semin Cell Dev Biol"},{"key":"3689_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399405009294","volume":"7","author":"DT Warren","year":"2005","unstructured":"Warren DT, Zhang Q, Weissberg PL, Shanahan CM (2005) Nesprins: intracellular scaffolds that maintain cell architecture and coordinate cell function? Expert Rev Mol Med 7:1\u201315","journal-title":"Expert Rev Mol Med"},{"key":"3689_CR119","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jalz.2016.06.006","volume":"12","author":"MR Khanna","year":"2016","unstructured":"Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR (2016) Therapeutic strategies for the treatment of tauopathies: hopes and challenges. Alzheimers Dement 12:1051\u20131065","journal-title":"Alzheimers Dement"},{"key":"3689_CR120","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1021\/mp060012c","volume":"3","author":"JA Subramony","year":"2006","unstructured":"Subramony JA (2006) Apomorphine in dopaminergic therapy. Molecular pharmaceutics 3:380\u2013385","journal-title":"Molecular pharmaceutics"},{"key":"3689_CR121","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1517\/14656566.2013.782002","volume":"14","author":"P D'Amelio","year":"2013","unstructured":"D'Amelio P, Isaia GC (2013) The use of raloxifene in osteoporosis treatment. Expert opinion on pharmacotherapy 14:949\u2013956","journal-title":"Expert opinion on pharmacotherapy"},{"key":"3689_CR122","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.0000000000002171","volume":"85","author":"VW Henderson","year":"2015","unstructured":"Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR (2015) Raloxifene for women with Alzheimer disease: a randomized controlled pilot trial. Neurology 85:1937\u20131944","journal-title":"Neurology"},{"key":"3689_CR123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pneurobio.2017.08.003","volume":"158","author":"JR Kulbe","year":"2017","unstructured":"Kulbe JR, Hall ED (2017) Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology. Prog Neurobiol 158:15\u201344","journal-title":"Prog Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03689-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03689-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03689-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T02:26:59Z","timestamp":1713925619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03689-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":123,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3689"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03689-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3163861\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2023.05.13.540661","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}